These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12964503)

  • 1. Intraportal donor bone marrow transplantation improves intestinal allograft survival in rats under FK506-based immunosuppression.
    Sun DS; Yagi T; Oyama T; Matsukawa H; Matsuda H; Sadamori H; Inagaki M; Matsuoka J; Iwagaki H; Tanaka N
    J Int Med Res; 2003; 31(4):281-9. PubMed ID: 12964503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of tacrolimus and bone marrow augmentation on intestinal allograft survival and intragraft cytokine expression in rats.
    Nakao A; Kobayashi E; Shen SD; Yoshino T; Tanaka N
    J Med; 2001; 32(3-4):207-30. PubMed ID: 11563819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effect of donor-specific bone marrow transplantation via portal vein and FK506 on small bowel transplantation in the rat.
    Nakao A; Yagi T; Matsukawa H; Endo A; Okada Y; Sun DS; Sadamori H; Inagaki M; Matsuno T; Tanaka N
    Transplant Proc; 2000 Nov; 32(7):2011-2. PubMed ID: 11120044
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of portal infusion with donor-derived bone marrow cells and intracellular cytokine expression of graft-infiltrating lymphocytes on the graft survival in rat small bowel transplant model.
    Mitsuoka N; Iwagaki H; Ozaki M; Sheng SD; Sadamori H; Matsukawa H; Morimoto Y; Matsuoka J; Tanaka N; Yagi T
    Transpl Immunol; 2004 Nov; 13(3):155-60. PubMed ID: 15381197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between allograft survival and chimeric state after bone marrow infusion in rat small bowel transplantation.
    Bakonyi Neto A; Ricordi C; Feo CF; Porcu A; Misiakos EP; Gandia C; Ruiz P; Bertho M; Carreno M; Esquenazi V; Miller J; Tzakis AG
    Pediatr Transplant; 1999 Feb; 3(1):67-73. PubMed ID: 10359034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-derived bone marrow transfusion produces mixed chimerism and promotes a Th2 shift in Th1/Th2 balance in rat heterotopic small bowel transplantation.
    Hu A; Li Q; Shi H; Tai Q; Wu L; Xiong J; Fu B; He X
    Dig Liver Dis; 2012 Dec; 44(12):988-94. PubMed ID: 22954489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged survival of donor-specific rat intestinal allograft by administration of bone-marrow-derived immature dendritic cells.
    Sheng Sun D; Iwagaki H; Ozaki M; Ogino T; Kusaka S; Fujimoto Y; Murata H; Sadamori H; Matsukawa H; Tanaka N; Yagi T
    Transpl Immunol; 2005 Mar; 14(1):17-20. PubMed ID: 15814277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine mRNA expression on rat small bowel allograft treated with tacrolimus and simultaneous bone marrow transplantation via the portal vein.
    Nakao A; Yagi T; Sun DS; Matsukawa H; Endo A; Okada Y; Sadamori H; Inagaki M; Matsuno T; Tanaka N
    Transplant Proc; 2000 Sep; 32(6):1318-9. PubMed ID: 10995965
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistence of donor cells and incidence of graft-versus-host disease after simultaneous small bowel and bone marrow transplantation.
    Ye Q; Demetris AJ; Galvao FH; Toyama Y; Doughton CS; Todo S; Starzl TE; Murase N
    Transplant Proc; 1996 Oct; 28(5):2453. PubMed ID: 8907895
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of a calcineurin inhibitor, FK506, and a CCR5/CXCR3 antagonist, TAK-779, in a rat small intestinal transplantation model.
    Takama Y; Miyagawa S; Yamamoto A; Firdawes S; Ueno T; Ihara Y; Kondo A; Matsunami K; Otsuka H; Fukuzawa M
    Transpl Immunol; 2011 Jul; 25(1):49-55. PubMed ID: 21515370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation.
    Miyauchi T; Ishikawa M; Tashiro S; Hisaeda H; Nagasawa H; Himeno K
    Transplantation; 1998 Jan; 65(1):27-32. PubMed ID: 9448139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of donor and recipient strains in isolated small bowel transplantation in rats.
    Tanabe M; Murase N; Demetris AJ; Hoffman RA; Nakamura K; Fujisaki S; Galvao FH; Todo S; Fung J; Starzl TE
    Transplant Proc; 1994 Dec; 26(6):3733-40. PubMed ID: 7527986
    [No Abstract]   [Full Text] [Related]  

  • 14. Graft persistence effectively induces and maintains donor-specific unresponsiveness.
    Nishinaka H; Nakafusa Y; Hirano T; Takeda K; Kawano R; Nakano M; Arima T; Nakamura K; Kamei T; Tanaka M
    J Surg Res; 1997 Mar; 68(2):145-52. PubMed ID: 9184673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of allo-intestinal graft survival and intragraft cytokine expression by bone marrow augmentation with tacrolimus treatment in rats.
    Nakao A; Sun DS; Inagaki M; Sadamori Y; Yagi T; Tanaka N
    Transplant Proc; 2001; 33(1-2):340-1. PubMed ID: 11266851
    [No Abstract]   [Full Text] [Related]  

  • 16. Recipient FK506 pretreatment regimens in rat small bowel transplantation: allograft survival, function, and systemic infection.
    Guo WH; Tian L; Yuen ZW; Chan KL; Wo JY; Nicholls G; Dallman M; Tam PK
    J Pediatr Surg; 2000 Nov; 35(11):1600-5. PubMed ID: 11083432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune tolerance induced by donor antigen and cyclophosphamide in rat fetal small bowel transplantation.
    Nakao M; Taguchi T; Ogita K; Nishimoto Y; Suita S
    Fukuoka Igaku Zasshi; 2005 Feb; 96(2):49-57. PubMed ID: 15852663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloablative irradiation, granulocyte-colony stimulating factor, and FK506 can induce macrochimerism and prolong the survival of experimental extremity allografts.
    Muramatsu K; Kato H; Yoshida Y; Moriya A; Okimoto T; Taguchi T
    J Surg Res; 2011 Dec; 171(2):807-13. PubMed ID: 20538288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine.
    Wachtman GS; Wimmers EG; Gorantla VS; Lin CH; Schneeberger S; Unadkat JV; Zheng XX; Brandacher G; Lee WP
    Transplant Proc; 2011 Nov; 43(9):3541-4. PubMed ID: 22099837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.